Publications
5532 Results
- Journal / Conference
- ASCO 13:177(#496)
- Year
- 1994
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-8737
Phase III randomized trial of infusional AZQ (diaziquone) versus IV BCNU for supratentorial malignant astrocytoma (MA): SWOG 8737.
- Journal / Conference
- ASCO 13:337(#1120)
- Year
- 1994
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8805
Concurrent cisplatin/etoposide (PE) plus chest radiation followed by surgery for stages 3A(N2) and 3B non-small cell lung cancer: Completed analysis of SWOG-8805.
- Journal / Conference
- ASCO 13:249(#782)
- Year
- 1994
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8835
Intraperitoneal (IP) mitoxantrone vs. intraperitoneal floxuridine in ovarian cancer patients with minimal residual disease after second-look surgery, a randomized phase II pilot.
- Journal / Conference
- ASCO 13:398(#1357)
- Year
- 1994
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8913
Phase II evaluation of merbarone in disseminated malignant melanoma: A Southwest Oncology Group study.
- Journal / Conference
- ASCO 13:333(#1105)
- Year
- 1994
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9252 (INT-0115) (EST-3590) (RTOG 91-05) (NCCTG-91-24-51) (CALGB-9393)
Cisplatin (P) & etoposide (E) + concurrent thoracic radiotherapy (TRT) administered once versus twice daily for limited-stage (LS) small cell lung cancer (SCLC): Preliminary results of an intergroup trial.
- Journal / Conference
- American Association for Cancer Research 35:194(#1160)
- Year
- 1994
Trisomy II in acute myeloid leukemia: a non-random chromosomal aberration associated with a stem cell phenotype.
- Journal / Conference
- ASCO 13:188(#539)
- Year
- 1994
Analysis of Southwest Oncology Group (SWOG) accrual for sex ratios and associated socioeconomic status (SES) factors.
- Journal / Conference
- Leukemia 8(Suppl.2):S38-S41
- Year
- 1994
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8124/25/26, SWOG-8522, SWOG-8561, SWOG-8600, SWOG-8706
Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.
- Journal / Conference
- Journal of Clinical Oncology 12(11):2405-2414
- Year
- 1994
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8624